Vitamin D supplementation may cut dementia incidence
Mar 08, 2023
Any vitamin D supplement exposure was associated with a 40% lower dementia incidence.
Partnership provides dementia best practices training for senior living staff
By
Kimberly Bonvissuto
Mar 07, 2023
A Massachusetts-based senior living provider is partnering with a New York-based Alzheimer’s and dementia caregiving organization to provide staff training on best practices for caring with residents...
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
Social isolation contributes to increased likelihood of dementia: study
By
Kimberly Bonvissuto
Jan 11, 2023
Social isolation is common among older adults in the United States — experienced by one in four of them — and increases the likelihood of developing dementia, according to the results of a new study.
FDA approves second drug for Alzheimer’s disease, despite safety concerns
Jan 06, 2023
The approval of lecanemab-irmb (Leqembi) comes after controversial approval in 2021 of aducanumab (Aduhelm), which met with criticism over concerns about that drug’s effectiveness, safety and pricing.
PTSD, TBI interact with APOE ε4 to raise Alzheimer, dementia risk
Jan 06, 2023
Significant additive APOE ε4 interactions were seen with PTSD and TBI in veterans of European ancestry.
Subjective cognitive decline tied to incident dementia in Black, Latinx individuals
Dec 01, 2022
Subjective cognitive decline was associated with increased rates of incident dementia over time in the multiracial population, Latinx and non-Latinx Black individuals.
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.
Progress made in Alzheimer’s research and lifestyle interventions, NIH says
By
Kimberly Bonvissuto
Nov 30, 2022
The burden of Alzheimer’s disease and related dementias is significant, according to the National Institutes of Health. But scientists have made progress in drug development, lifestyle interventions,...
More news for Wednesday, Nov. 30
By
Kimberly Bonvissuto
Nov 30, 2022
Resources empower older adults to plan for changes in driving, firearm use: study … 40% of older adult brains show signs of LATE dementia … Amazon launches Alexa Smart Properties for Senior Living...